⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TTRX News
Turn Therapeutics Inc. Common Stock
Form 8-K
sec.gov
TTRX
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
businesswire.com
TTRX
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
TTRX
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
globenewswire.com
TTRX